Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

ClinicalTrials.gov ID: NCT00604760

Public ClinicalTrials.gov record NCT00604760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To establish the proof of concept that MEM 3454, used as add-on pharmacotherapy, is a safe and effective treatment in patients with cognitive impairment associated with schizophrenia (CIAS).

Study identification

NCT ID
NCT00604760
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Memory Pharmaceuticals
Industry
Enrollment
160 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2007 (Type not available)
Primary completion
Feb 2009 (Estimated)
Completion
Not listed
Last update posted
Dec 8, 2008

Started 2007

United States locations

U.S. sites
44
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Telecare-Cresta Loma Lemon Grove California 91945 —
Newport Bay Hospital Newport Beach California 92663 —
Excell Research Oceanside California 92056 —
Pasadena Research Institute Pasadena California 91107 —
BHC Alhambra Hospital Rosemead California 91770 —
California Clinical Trials Medical Group San Diego California 92123 —
Neuropsychiatric Research Center of Orange County Santa Ana California 92701 —
Coastal Communities Hospital Santa Ana California 92704 —
Collaborative NeuroScience Network, Inc. Torrance California 90502 —
Aventura Hospital Aventura Florida 33180 —
Fort Lauderdale Hospital Fort Lauderdale Florida 33301 —
Aventura Hospital Miami Florida 33180 —
TuKoi Clinical Research Miami Florida 33180 —
Professional Clinical Research, Inc. c/o Segal Institute for Clinical Research North Miami Florida 33161 —
Scientific Clinical Research, Inc. North Miami Florida 33161 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Berwyn Rehabilitation Center Berwyn Illinois 60402 —
Alexian Brothers Behavioral Health Hospital Hoffman Estates Illinois 60169 —
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169 —
Chinmay K. Patel, DO Hoffman Estates Illinois 60169 —
American Medical Research, Inc. Oak Brook Illinois 60523 —
Clinical Research Institute Wichita Kansas 67207 —
Parkwood Behavioral Health System Olive Branch Mississippi 38654 —
St. Louis Clinical Trials, LC St Louis Missouri 63118 —
CRI Worldwide, LLC at Lourdes Medical Center of Burlington County Willingboro New Jersey 08046 —
CRI Worldwide, LLC Willingboro New Jersey 08046 —
Sooner Clinical Research Oklahoma City Oklahoma 73112 —
Arthur P. Noyes Research Foundation Norristown Pennsylvania 19401 —
CRC Worldwide, LLC Philadelphia Pennsylvania 19139 —
Carolina Clinical Trials, Inc. Charleston South Carolina 29405 —
Centerstone Madison Tennessee 37115 —
Research Strategies of Memphis, LLC Memphis Tennessee 38117 —
Vogelfanger and Struble Clinic Memphis Tennessee 38119 —
Lakeside Behavioral Health System Memphis Tennessee 38133 —
Centerstone - Ella Hayes Center Nashville Tennessee 37208 —
Vanderbilt Psychiatric Hospital Nashville Tennessee 37212-8645 —
Centerstone - Frank Luton Center Nashville Tennessee 37217 —
Texas NeuroRehab Center, Pecos Unit Austin Texas 78745 —
Community Clinical Reserarch, Inc. Austin Texas 78754 —
FutureSearch Trials Austin Texas 78756 —
University Hills Clinical Research Irving Texas 75062 —
Poplar Springs Hospital Petersburg Virginia 23805 —
International Clinical Research Associates, LLC Richmond Virginia 23229 —
Pacific Institute of Medical Sciences Bothell Washington 98011 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00604760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2008 · Synced Nov 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00604760 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →